Enterome utilizing drug-device combos to battle Crohn's disease
This article was originally published in Scrip
Executive Summary
The gut microbiome is becoming a bit of a buzzword in healthcare, amid growing evidence of its importance in diseases ranging from Crohn's and diabetes to multiple sclerosis. French venture capitalist Seventure Partners even has a fund dedicated to microbiome-based investments.